Share

March 17, 2015; 84 (11) Article

Effects of vascular risk factors and APOE ε4 on white matter integrity and cognitive decline

Rui Wang, Laura Fratiglioni, Erika J. Laukka, Martin Lövdén, Grégoria Kalpouzos, Lina Keller, Caroline Graff, Alireza Salami, Lars Bäckman, Chengxuan Qiu
First published February 11, 2015, DOI: https://doi.org/10.1212/WNL.0000000000001379
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
598

Share

Article Information

vol. 84 no. 11 1128-1135
DOI: 
https://doi.org/10.1212/WNL.0000000000001379
PubMed: 
25672924
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received August 18, 2014
  • Accepted in final form November 24, 2014
  • First Published February 11, 2015.

Article Versions

Copyright & Usage: 
© 2015 American Academy of Neurology

Author Disclosures

    1. Rui Wang, MSc,
    2. Laura Fratiglioni, PhD,
    3. Erika J. Laukka, PhD,
    4. Martin Lövdén, PhD,
    5. Grégoria Kalpouzos, PhD,
    6. Lina Keller, PhD,
    7. Caroline Graff, PhD,
    8. Alireza Salami, PhD,
    9. Lars Bäckman, PhD and
    10. Chengxuan Qiu, PhD
  1. Rui Wang, MSc,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Laura Fratiglioni, PhD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Erika J. Laukka, PhD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. (1) the Swedish Research Council, (2)Swedish Research Council for Health, Working Life and Welfare

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Martin Lövdén, PhD,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1)FORTE, 2013-2277, PI, 2014-2018. (2) Swedish Research Council, 446-2013-7189, PI, 2014-2019,

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Grégoria Kalpouzos, PhD,
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Lina Keller, PhD,
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. Caroline Graff, PhD,
    8. Scientific Advisory Boards:

    1. 1) (non-profit) Academic research Data Access Committee member for GENFI since 2014

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Invited speaker att Swedish BRain Foundation oktober and november 2014 Invited speaker Swedish Alzheimer foundation 2014

    Editorial Boards:

    1. NONE

    Patents:

    1. Co-inventor in three patents Number and (year): Nr: JP2005- 044776(2005); Nr: JP2010-48067 (2010); Nr EP14158408 (2014)

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Year Funding Agency 2011-2013 Swedish Research Council, no. 21738 research grant

    Research Support, Academic Entities:

    1. Year Funding Agency role 2011-2014 KID PhD-student funding, KI research grant 2006-2011 KID PhD-student funding, KI research grant

    Research Support, Foundations and Societies:

    1. 2015 SCILIFELAB PROJECT FUNDING FOR 100 WHOLE GENOMES OF FAMILIAL EARLY ONSET DEMENTIA CASES, 700K KR 2015-17 CO-APPLICANT IN JPND PREFRONTALS AND CURRENTLY NEGOTIATING FUNDING AMOUNT WITH VR (SWEDISH RESEARCH COUNCIL) (PI JAN VAN SWIETEN, AMSTERDAM) 2015-17 CO-APPLICANT IN JPND DAMNDPATHS AND MY FUNDING AMOUNT FROM VR IS 1379 K KR (PI EVA HEDLUND, STOCKHOLM) 2014 CO-APPLICANT IN JPND WORKING GROUP PRENI TOTAL 50K EUR (PI JONATHAN ROHRER, LONDON) 2006-16 ALF-PROJECT FUNDING (SLL) 5 000K KR 2014 SWEDISH BRAIN FOUNDATION 500K KR 2013-17 CO-APPLICANT IN JPND RHAPSODY AND RECEIVED VR-FUNDING 1 881K KR (PI ALEXANDER KURZ, MUNICH) 2013-16 CO-APPLICANT AGING AND HEALTH SWEDISH RESEARCH COUNCIL 12 144K KR (PI LAURA FRATIGLIONI KI) 2013-14 CO-APPLICANT MAYO CLINIC- KI COLLABORATION GRANT 30K USD (PIS C GRAFF AND KF BIENIEK & D DICKSON) 2010-14 ROCHE POSTDOC FELLOW FUNDING 464K CHF 2013-14 SWEDISH ALZHEIMER FOUNDATION 1 750K KR 2006-14 KI FUNDING FROM STRATNEURO 3075 K SEK & KI- DOCTORAL FUNDING 2 148K KR 2013-15 CORE FACILITY FUNDING FOR BRAIN BANK AT KI 1 500K KR 2012-15 MY SALARY AS MANAGER FOR THE BRAIN BANK AT KI FROM KI STRATNEURO 2012-13 GRANT FOR THE BRAIN BANK AT KI FROM KI STRATNEURO 1500K KR 2005-15 SWEDISH BRAIN POWER 3 556K KR 2011-13 SWEDISH RESEARCH COUNCIL, TOTAL 1 650K KR 2009- 11 MARIANNE AND MARKUS WALLENBERG FOUNDATION FOR CLINICAL RESEARCHERS. 75% SALARY FOR 3 YEARS AND 700K KR PER YEAR IN PROJECT FUNDING. 2010-14 KING GUSTAF V AND QUEEN VICTORIA?S FREE MASONS FOUNDATION: 1 100K KR

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  8. Alireza Salami, PhD,
    9. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  9. Lars Bäckman, PhD and
    10. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Aging, Neuropsychology, and Cognition

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Swedish Research Council Swedish Council for Working Life and Social Research Swedish Brain Power Alexander von Humboldt Foundation af Jochnick Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  10. Chengxuan Qiu, PhD
    11. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Journal of Alzheimer Disease, Associated Editor, 2010- 2013.

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. The Swedish Research Council, Project no. K2008-69X-20821-01-3, Years 2008-2012 and K2012-99X-21967-01-3, Years 2012-2015. (3) The Swedish Council for Working Life and Social Research, Grant No. 2007-1172, Years 2008-2012 and 2014-1382, Years 2015-2018.

    Research Support, Academic Entities:

    1. Karolinska Institutet, Stockholm, Sweden

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Aging Research Center (R.W., L.F., E.J.L., M.L., G.K., L.K., A.S., L.B., C.Q.), Department of Neurobiology, Care Sciences and Society, Karolinska Institutet–Stockholm University; Stockholm Gerontology Research Center (L.F., L.B.); and Division of Neurogeriatrics (C.G.), Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Center for Alzheimer Research at Karolinska Institutet, Sweden.
  1. Correspondence to Rui Wang: rui.wang{at}ki.se or Dr. Qiu: chengxuan.qiu{at}ki.se
View Full Text

Article usage

Article usage: March 2015 to April 2023

AbstractFullPdfSource
Feb 2015321036Highwire
Mar 201510983056Highwire
Apr 20152331219Highwire
May 201512074Highwire
Jun 201589119Highwire
Jul 201542167Highwire
Aug 2015551613Highwire
Sep 20153733Highwire
Sep 20150159pmc
Oct 20152585Highwire
Oct 201503025pmc
Nov 20153787Highwire
Nov 201503027pmc
Dec 20152943Highwire
Dec 201503117pmc
Jan 201692119Highwire
Jan 201603221pmc
Feb 20162841Highwire
Feb 201601410pmc
Mar 20163233Highwire
Mar 201602014pmc
Apr 20161321Highwire
Apr 20160229pmc
May 20162500Highwire
May 201602810pmc
Jun 20162501Highwire
Jun 201602317pmc
Jul 20161101Highwire
Jul 201602213pmc
Aug 20163342Highwire
Aug 20160118pmc
Sep 20161710Highwire
Sep 201601913pmc
Oct 20163011Highwire
Oct 20160206pmc
Nov 20162411Highwire
Nov 20160139pmc
Dec 20162200Highwire
Dec 20160147pmc
Jan 20171434Highwire
Jan 20170148pmc
Feb 20172001Highwire
Feb 20170137pmc
Mar 20171014Highwire
Mar 20170214pmc
Apr 20171433Highwire
Apr 2017111718pmc
May 20171522Highwire
May 2017243pmc
Jun 20171100Highwire
Jun 2017101011pmc
Jul 2017902Highwire
Jul 2017466pmc
Aug 20172000Highwire
Aug 2017256pmc
Sep 2017611Highwire
Sep 2017388pmc
Oct 20171731Highwire
Oct 2017101112pmc
Nov 20171200Highwire
Nov 201751317pmc
Dec 20172000Highwire
Jan 20181401Highwire
Feb 20183400Highwire
Mar 20181100Highwire
Apr 20182401Highwire
Apr 201861515pmc
May 20182301Highwire
Jun 20182441Highwire
Jun 201841112pmc
Jul 20182111Highwire
Aug 2018901Highwire
Aug 2018377pmc
Sep 20181701Highwire
Oct 20181730Highwire
Nov 20182801Highwire
Dec 20181400Highwire
Jan 20191610Highwire
Feb 20193121Highwire
Mar 20193001Highwire
Apr 20191811Highwire
May 20191811Highwire
Jun 20191200Highwire
Jul 20191776Highwire
Aug 20191130Highwire
Sep 20193611Highwire
Oct 20191512Highwire
Nov 20193950Highwire
Dec 20192300Highwire
Jan 20201500Highwire
Feb 20202521Highwire
Mar 20201711Highwire
Apr 20201501Highwire
May 20201710Highwire
Jun 20201711Highwire
Jul 20201411Highwire
Aug 20204211Highwire
Sep 20201131Highwire
Oct 20203021Highwire
Nov 20202610Highwire
Dec 20201220Highwire
Jan 20212910Highwire
Feb 20214523Highwire
Mar 20213431Highwire
Apr 20214132Highwire
May 20212220Highwire
Jun 20213810Highwire
Jul 20212310Highwire
Aug 20212731Highwire
Sep 20211510Highwire
Oct 20213410Highwire
Nov 20212821Highwire
Dec 20213921Highwire
Jan 20222010Highwire
Feb 20225222Highwire
Mar 20223910Highwire
Apr 20222840Highwire
May 20224110Highwire
Jun 20223222Highwire
Jul 20223521Highwire
Aug 20223710Highwire
Sep 20222900Highwire
Oct 20224811Highwire
Nov 20222812Highwire
Dec 20224021Highwire
Jan 20234010Highwire
Feb 20232911Highwire
Mar 20234220Highwire
Apr 20233131Highwire

Cited By...

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Topics Discussed

Alert Me

Recommended articles